Pharming Group N.V. (PHAR)

Pharming Group Revenue

In the year 2025, Pharming Group had annual revenue of $376.13M with 26.56% growth. Pharming Group had revenue of $106.50M in the quarter ending December 31, 2025, with 14.89% growth.

• Revenue (ttm): $376.09M
• Revenue Growth: +26.53%
• P/S Ratio: 3.12
• Revenue / Employee: $924,162
• Employees: 407
• Market Cap: 1.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	376.13M	78.93M	26.56%
Dec 31, 2024	297.20M	51.88M	21.15%
Dec 31, 2023	245.32M	39.69M	19.30%
Dec 31, 2022	205.62M	6.75M	3.39%
Dec 31, 2021	198.87M	-13.30M	-6.27%
Dec 31, 2020	212.17M	22.79M	12.03%
Dec 31, 2019	189.39M	34.10M	21.96%
Dec 31, 2018	155.29M	47.75M	44.40%
Dec 31, 2017	107.54M	90.83M	543.88%
Dec 31, 2016	16.70M	4.94M	42.05%
Dec 31, 2015	11.76M	-13.88M	-54.13%
Dec 31, 2014	25.63M	16.22M	172.36%
Dec 31, 2013	9.41M	-4.59M	-32.77%
Dec 31, 2012	14.00M	10.12M	260.60%
Dec 31, 2011	3.88M	3.12M	406.76%
Dec 31, 2010	766.09K	285.75K	59.49%
Dec 31, 2009	480.35K	-445.02K	-48.09%
Dec 31, 2008	925.37K	-83.21K	-8.25%
Dec 31, 2007	1.01M	815.16K	421.44%
Dec 31, 2006	193.42K	-285.11K	-59.58%
Dec 31, 2005	478.53K	-	-